Straumann Holding AG

Switzerland Country flag Switzerland
Sector: Medical Supplies
Ticker: STMN
ISIN: CH1175448666
Factsheet Factsheet

Market multiple valuation of Straumann Holding AG ( STMN | CHE)

The most common multiple used in the valuation of stocks is the P/Earnings NTM multiple (Price to Earnings). P/E relates the current share price with the market expectations in terms of Earnings Per Share. This multiple is used to compare a company's market value with its earnings. A company with a high P/Earnings NTM is considered to be overvalued; a company with a low P/Earnings NTM is considered to be undervalued.
The P/Earnings NTM ratio of Straumann Holding AG is significantly higher than the median of its peer group: around 14.00. The company valuation of Straumann Holding AG according to these metrics is way above the market valuation of its peer group.
The P/Earnings NTM ratio of Straumann Holding AG is significantly higher than the average of its sector (Medical Supplies): 16.39. The company valuation of Straumann Holding AG according to these metrics is way above the market valuation of its sector.
The P/Earnings NTM ratio of Straumann Holding AG is significantly lower than its historical 5-year average: 43.2. The (current) company valuation of Straumann Holding AG is therefore way below its valuation average over the last five years.

Valuation
P/E Last P/E (e) 2024P/E NTM
Straumann Holding AGFree trialFree trialFree trial
International PeersFree trialFree trialFree trial
Medical Supplies9.7614.5216.39
SMI22.3319.0218.22
Switzerland16.1918.3015.18
More...
Beta (Ref: SMI)
Levered betaUnlevered beta
1-Year1.591.59
2-Year1.621.62
3-Year1.581.58
More...
Stock Perf excl. Dividends (in CHF)
STMNSMIRel. Perf.
Year-to-Date-6.6%6.6%-13.2%
1-Week1.1%1.1%-0.0%
1-Month5.0%1.1%3.9%
1-Year-9.5%1.0%-10.6%
3-Year-9.5%7.3%-16.8%
5-Year32.3%21.4%11.0%
More...
International Peers - Straumann Holding AG
Company NameCtryMarket
Cap.
last (mUSD)
Straumann Holding AGCHE-0.00
International Peers Median0.69
DENTSPLY SIRONA Inc.USA3 231
Medartis Holding AGCHE-0.00
Zimmer Biomet Holdings ...USA18 390
Nakanishi Inc.JPN-0.00
CONMED Corp.USA1 736
GPRV Analysis
Created with Highcharts 4.1.70/102/104/106/108/1010/10
Straumann Holding AG
Intl. Peers
U.S Patents No. 7,882,001 & 8,082,201
More...
Net Sales Chart
Created with Highcharts 4.1.7Millions CHF201920202021202220232024 (e)2025 (e)2026 (e)2027 (e)0k2k4k
More...
Quotes Chart

1-Year Rebased Stock Chart

  • Straumann Holding AG
  • SMI
Created with Highcharts 4.1.7Jan '25Sep '24May '25-40%-20%0%20%
More...

Did you know ?

Multiples charts provide an effective way to quickly analyze a company's valuation over a period of time, and compare it against the valuation of another company, a personal list, or a market index.

About Market Multiples

Many methods can be used to value a company. In reality, business valuation is often a combination of these different approaches. One of the most widely used quantitative methods is the market multiples method. The market valuation is utilized generally as a primary market input, to provide an objective starting point for the valuation. Put simply, this method multiplies the sales or profits of a business by an industry averaged multiplier to calculate the Market Value of the business.
Current multiples include:
- Historical multiples based on standardized financials for the last completed fiscal period: Last, Last Twelve Months (LTM);
- Forward multiples based on consensus estimates for the current fiscal period and next ones: Next Twelve Months (NTM), FY0, FY1.
Current multiples based on per-share metrics (such as earnings per share or book value per share) are calculated using the last closing price, while current multiples based on company-level metrics (such as net sales, EBIT or EBITDA) are calculated using the current market cap or EV (Enterprise Value).